Investor profile for BioGenerator Ventures: stage-based planning range, investment stages, sector focus, portfolio companies, sources, and verification status. Part of the Venture Capital Tracker directory.

VC fund profile · evidence-aware directory data

BioGenerator Ventures stages, portfolio and investment profile

St. Louis company-creation and early-stage investor focused on healthcare and agriculture. Part of the BioSTL ecosystem; BioGenerator dates to 2003 as a regional life-science formation engine. BioGenerator Ventures builds companies from concepts/EIRs, invests from an evergreen model, and syndicates with national venture and strategic capital. Sectors: therapeutics, diagnostics, research tools, and agtech. HQ St. Louis, MO.

Keep track of BioGenerator Ventures

Save this profile to your VCT watchlist for a quick return.

View watchlist

Stage-based planning range

$250K–$3M

This is a planning range inferred from stage coverage, not a firm-disclosed check size.

Methodology: Stage bucket inferred from the rounds a fund leads or invests in.

No firm-specific check-size disclosure is recorded.

Source link not recorded Confidence: 25% Verified: Not recorded View methodology

Investment stages

Leads: Pre-Seed, Seed

Participates: Pre-Seed, Seed, Series A

Sector focus

biotech-life-sciences · healthtech · climate-tech · deep-tech

Geography

St. Louis, MO

Founded 2003

Fund size / AUM

Not recorded

A separate fund-size evidence record is not yet available.

Portfolio in our directory

None yet

Linked startup profiles

Latest fund vehicle

Not recorded

Vehicle name, size, and vintage are not yet structured.

Recent tracked investment

Not recorded

No dated round explicitly links this fund.

Rounds they lead

Pre-Seed Seed

Rounds they invest

Pre-Seed Seed Series A

Last verified: Not recorded. Check-size evidence is labeled by basis so planning estimates are not presented as firm disclosures.

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.